SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹51 Cr | ₹48 Cr | ₹43 Cr | ₹41 Cr | ₹40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹51 Cr |
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹40 Cr |
How is Deferred Tax Assets / Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹51 Cr | 5.65 | |
| Mar2025 | ₹48 Cr | 12.38 | |
| Mar2024 | ₹43 Cr | 4.34 | |
| Mar2023 | ₹41 Cr | 3.71 | |
| Mar2022 | ₹40 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹4,418.9 Cr | -0.7% | 28.5% | 76.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -0.7% |
28.5% |
76.7% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses